J, B., SZ, A., BA, B., MJ, D., DW, K., MC, P., . . . MN, K. (2023). Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction.
Citación estilo ChicagoJ, Butler, et al. Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction. 2023.
Cita MLAJ, Butler, et al. Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction. 2023.
Precaución: Estas citas no son 100% exactas.